SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017242
Filing Date
2019-05-08
Accepted
2019-05-08 16:27:44
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scph-10q_20190331.htm 10-Q 980697
2 EX-10.2 scph-ex102_176.htm EX-10.2 255674
3 EX-31.1 scph-ex311_9.htm EX-31.1 10797
4 EX-32.1 scph-ex321_7.htm EX-32.1 8146
5 GRAPHIC gmrs5ovc2d5l000001.jpg GRAPHIC 11346
  Complete submission text file 0001564590-19-017242.txt   4638785

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scph-20190331.xml EX-101.INS 915723
7 XBRL TAXONOMY EXTENSION SCHEMA scph-20190331.xsd EX-101.SCH 41122
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20190331_cal.xml EX-101.CAL 43231
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20190331_def.xml EX-101.DEF 114135
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20190331_lab.xml EX-101.LAB 319371
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20190331_pre.xml EX-101.PRE 245858
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 19807002
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences